Genotypic and phenotypic characteristics of juvenile/adult onset vanishing white matter: a series of 14 Chinese patients.
Leukoencephalopathy
Ovarian failure
Provoking factors
VWM
Vanishing white matter
eIF2B
Journal
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
received:
13
01
2022
accepted:
14
03
2022
pubmed:
8
4
2022
medline:
6
8
2022
entrez:
7
4
2022
Statut:
ppublish
Résumé
Vanishing white matter (VWM) is one of the most prevalent leukoencephalopathies and is caused by recessive mutations in gene eIF2B1-5. The onset may vary from an antenatal disorder that is rapidly fatal to an adult-onset disorder with chronic progressive deterioration. Based on a comprehensive study of 14 juvenile/adult patients diagnosed in our department as well as a review of 71 previously reported cases of genetically confirmed juvenile/adult-onset VWM since 2001, we attempted to delineate the clinical symptoms, disease evolution, episodic aggravation, associated symptoms, MRI findings and genotypic characteristics of adult VWM. The onset age of neuropsychiatric symptoms was 23.4 ± 10.6 years, and the mean follow-up time was 8.1 ± 4.8 years. Major clinical symptoms included headache, epilepsy, cognitive decline, cerebellar ataxia, and urinary disturbances. Episodic aggravation was found in 42.9% of the patients in our series. Molecular studies revealed fourteen novel missense mutations. Diffuse abnormal signals characterized by T1-weighted hypointensity and T2-weighted hyperintensity were observed in the supratentorial white matter. The symmetrical leukoencephalopathy must be considered in patients of any age with premature ovarian failure or optic neuropathy. The VWM disease spectrum consists of characteristic imaging findings in combination with extremely wide variability in VWM patients.
Sections du résumé
BACKGROUND
BACKGROUND
Vanishing white matter (VWM) is one of the most prevalent leukoencephalopathies and is caused by recessive mutations in gene eIF2B1-5. The onset may vary from an antenatal disorder that is rapidly fatal to an adult-onset disorder with chronic progressive deterioration.
METHODS
METHODS
Based on a comprehensive study of 14 juvenile/adult patients diagnosed in our department as well as a review of 71 previously reported cases of genetically confirmed juvenile/adult-onset VWM since 2001, we attempted to delineate the clinical symptoms, disease evolution, episodic aggravation, associated symptoms, MRI findings and genotypic characteristics of adult VWM.
RESULTS
RESULTS
The onset age of neuropsychiatric symptoms was 23.4 ± 10.6 years, and the mean follow-up time was 8.1 ± 4.8 years. Major clinical symptoms included headache, epilepsy, cognitive decline, cerebellar ataxia, and urinary disturbances. Episodic aggravation was found in 42.9% of the patients in our series. Molecular studies revealed fourteen novel missense mutations. Diffuse abnormal signals characterized by T1-weighted hypointensity and T2-weighted hyperintensity were observed in the supratentorial white matter.
CONCLUSIONS
CONCLUSIONS
The symmetrical leukoencephalopathy must be considered in patients of any age with premature ovarian failure or optic neuropathy. The VWM disease spectrum consists of characteristic imaging findings in combination with extremely wide variability in VWM patients.
Identifiants
pubmed: 35389136
doi: 10.1007/s10072-022-06011-0
pii: 10.1007/s10072-022-06011-0
doi:
Substances chimiques
Eukaryotic Initiation Factor-2B
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
4961-4977Informations de copyright
© 2022. Fondazione Società Italiana di Neurologia.
Références
Vermeulen G, Seidl R, Mercimek-Mahmutoglu S, Rotteveel JJ, Scheper GC, van der Knaap MS (2005) Fright is a provoking factor in vanishing white matter disease. Ann Neurol 57:560–563
pubmed: 15786451
doi: 10.1002/ana.20418
Scali O, Di Perri C, Federico A (2006) The spectrum of mutations for the diagnosis of vanishing white matter disease. Neurol Sci 27:271–277
pubmed: 16998732
doi: 10.1007/s10072-006-0683-y
Bugiani M, Vuong C, Breur M, van der Knaap MS (2018) Vanishing white matter: a leukodystrophy due to astrocytic dysfunction. Brain Pathol 28:408–421
pubmed: 29740943
pmcid: 8028328
doi: 10.1111/bpa.12606
Keefe MD, Soderholm HE, Shih HY, Stevenson TJ, Glaittli KA, Bowles DM, Scholl E, Colby S, Merchant S, Hsu EW, Bonkowsky JL (2020) Vanishing white matter disease expression of truncated EIF2B5 activates induced stress response. Elife 10(9):e56319
Leferink PS, Breeuwsma N, Bugiani M, van der Knaap MS, Heine VM (2018) Affected astrocytes in the spinal cord of the leukodystrophy vanishing white matter. Glia 66:862–873
pubmed: 29285798
doi: 10.1002/glia.23289
Fogli A, Dionisi-Vici C, Deodato F, Bartuli A, Boespflug-Tanguy O, Bertini E (2002) A severe variant of childhood ataxia with central hypomyelination/vanishing white matter leukoencephalopathy related to EIF21B5 mutation. Neurology 59:1966–1968
pubmed: 12499492
doi: 10.1212/01.WNL.0000041666.76863.47
van der Knaap MS, van Berkel CG, Herms J, van Coster R, Baethmann M, Naidu S, Boltshauser E, Willemsen MA, Plecko B, Hoffmann GF, Proud CG, Scheper GC, Pronk JC (2003) eIF2B-related disorders: antenatal onset and involvement of multiple organs. Am J Hum Genet 73:1199–1207
pubmed: 14566705
pmcid: 1180499
doi: 10.1086/379524
van der Knaap MS, Barth PG, Gabreels FJ, Franzoni E, Begeer JH, Stroink H, Rotteveel JJ, Valk J (1997) A new leukoencephalopathy with vanishing white matter. Neurology 48:845–855
pubmed: 9109866
doi: 10.1212/WNL.48.4.845
Labauge P, Horzinski L, Ayrignac X, Blanc P, Vukusic S, Rodriguez D, Mauguiere F, Peter L, Goizet C, Bouhour F, Denier C, Confavreux C, Obadia M, Blanc F, de Seze J, Fogli A, Boespflug-Tanguy O (2009) Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases. Brain 132:2161–2169
pubmed: 19625339
doi: 10.1093/brain/awp171
Carra-Dalliere C, Horzinski L, Ayrignac X, Vukusic S, Rodriguez D, Mauguiere F, Peter L, Goizet C, Bouhour F, Denier C, Confavreux C, Obadia M, Blanc F, de Seze J, Sedel F, Guennoc AM, Sartori E, Laplaud D, Antoine JC, Fogli A, Boespflug-Tanguy O, Labauge P (2011) Natural history of adult-onset eIF2B-related disorders: a multicentric survey of 24 cases. Rev Neurol (Paris) 167:802–811
doi: 10.1016/j.neurol.2011.03.008
Hamilton EMC, van der Lei HDW, Vermeulen G, Gerver JAM, Lourenco CM, Naidu S, Mierzewska H, Gemke R, de Vet HCW, Uitdehaag BMJ, Lissenberg-Witte BI, Research Group V, van der Knaap MS (2018) Natural history of vanishing white matter. Annals Neurol 84:274–288
doi: 10.1002/ana.25287
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, Committee ALQA (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–424
pubmed: 25741868
pmcid: 4544753
doi: 10.1038/gim.2015.30
Fogli A, Rodriguez D, Eymard-Pierre E, Bouhour F, Labauge P, Meaney BF, Zeesman S, Kaneski CR, Schiffmann R, Boespflug-Tanguy O (2003) Ovarian failure related to eukaryotic initiation factor 2B mutations. Am J Hum Genet 72:1544–1550
pubmed: 12707859
pmcid: 1180314
doi: 10.1086/375404
Ohtake H, Shimohata T, Terajima K, Kimura T, Jo R, Kaseda R, Iizuka O, Takano M, Akaiwa Y, Goto H, Kobayashi H, Sugai T, Muratake T, Hosoki T, Shioiri T, Okamoto K, Onodera O, Tanaka K, Someya T, Nakada T, Tsuji S (2004) Adult-onset leukoencephalopathy with vanishing white matter with a missense mutation in EIF2B5. Neurology 62:1601–1603
pubmed: 15136690
doi: 10.1212/01.WNL.0000123117.11264.0E
Ohlenbusch A, Henneke M, Brockmann K, Goerg M, Hanefeld F, Kohlschutter A, Gartner J (2005) Identification of ten novel mutations in patients with eIF2B-related disorders. Hum Mutat 25:411
pubmed: 15776425
doi: 10.1002/humu.9325
Peter L, Niel F, Catenoix H, Jung J, Demarquay G, Petiot P, Rudigoz RC, Boespflug-Tanguy O, Ryvlin P, Mauguiere F (2008) Acute neurological deterioration in ovarioleukodystrophy related to EIF2B mutations: pregnancy with oocyte donation is a potentially precipitating factor. Eur J Neurol 15:94–97
pubmed: 18005052
doi: 10.1111/j.1468-1331.2008.02273.x
Lee HN, Koh SH, Lee KY, Ki CS, Lee YJ (2009) Late-onset vanishing white matter disease with compound heterozygous EIF2B5 gene mutations. Eur J Neurol 16:e42-43
pubmed: 19170749
doi: 10.1111/j.1468-1331.2008.02395.x
Matsukawa T, Wang X, Liu R, Wortham NC, Onuki Y, Kubota A, Hida A, Kowa H, Fukuda Y, Ishiura H, Mitsui J, Takahashi Y, Aoki S, Takizawa S, Shimizu J, Goto J, Proud CG, Tsuji S (2011) Adult-onset leukoencephalopathies with vanishing white matter with novel missense mutations in EIF2B2, EIF2B3, and EIF2B5. Neurogenetics 12:259–261
pubmed: 21484434
doi: 10.1007/s10048-011-0284-7
Ghezzi L, Scarpini E, Rango M, Arighi A, Bassi MT, Tenderini E, De Riz M, Jacini F, Fumagalli GG, Pietroboni AM, Galimberti D, Bresolin N (2012) A 66-year-old patient with vanishing white matter disease due to the p.Ala87Val EIF2B3 mutation. Neurology 79:2077–2078
pubmed: 23115207
doi: 10.1212/WNL.0b013e3182749edc
La Piana R, Vanderver A, van der Knaap M, Roux L, Tampieri D, Brais B, Bernard G (2012) Adult-onset vanishing white matter disease due to a novel EIF2B3 mutation. Arch Neurol 69:765–768
pubmed: 22312164
pmcid: 4154510
doi: 10.1001/archneurol.2011.1942
van der Lei HD, Steenweg ME, Bugiani M, Pouwels PJ, Vent IM, Barkhof F, van Wieringen WN, van der Knaap MS (2012) Restricted diffusion in vanishing white matter. Arch Neurol 69:723–727
pubmed: 22312162
Valalik I, van der Knaap MS, Scheper GC, Jobbagy A, Liptai Z, Csokay A (2012) Long-term tremor control with bilateral Vim-DBS in vanishing white matter disease. Parkinsonism Relat Disord 18:1048–1050
pubmed: 22632853
doi: 10.1016/j.parkreldis.2012.05.001
Zhang H, Dai L, Chen N, Zang L, Leng X, Du L, Wang J, Jiang Y, Zhang F, Wu X, Wu Y (2015) Fifteen novel EIF2B1–5 mutations identified in Chinese children with leukoencephalopathy with vanishing white matter and a long term follow-up. PLoS One 10:e0118001
pubmed: 25761052
pmcid: 4356545
doi: 10.1371/journal.pone.0118001
Shimada S, Shimojima K, Sangu N, Hoshino A, Hachiya Y, Ohto T, Hashi Y, Nishida K, Mitani M, Kinjo S, Tsurusaki Y, Matsumoto N, Morimoto M, Yamamoto T (2015) Mutations in the genes encoding eukaryotic translation initiation factor 2B in Japanese patients with vanishing white matter disease. Brain Dev 37:960–966
pubmed: 25843247
doi: 10.1016/j.braindev.2015.03.003
Ibitoye RT, Renowden SA, Faulkner HJ, Scolding NJ, Rice CM (2016) Ovarioleukodystrophy due to EIF2B5 mutations. Pract Neurol 16:496–499
pubmed: 27651498
doi: 10.1136/practneurol-2016-001382
Lynch DS, Rodrigues Brandao de Paiva A, Zhang WJ, Bugiardini E, Freua F, Tavares Lucato L, Macedo-Souza LI, Lakshmanan R, Kinsella JA, Merwick A, Rossor AM, Bajaj N, Herron B, McMonagle P, Morrison PJ, Hughes D, Pittman A, Laura M, Reilly MM, Warren JD, Mummery CJ, Schott JM, Adams M, Fox NC, Murphy
Humayun M, Khan A (2018) Case Report: Cerebral leukodystrophy and the gonadal endocrinopathy: a rare but real association. F1000Res 7:158
pubmed: 29721306
pmcid: 5915757
doi: 10.12688/f1000research.13933.1
Villar-Quiles RN, Delgado-Suarez C, Jorquera-Moya M, Arpa-Gutierrez J, Ortega-Suero G (2018) Teaching NeuroImages: Adult-onset vanishing white matter disease. Neurology 90:e1091–e1092
pubmed: 29555891
doi: 10.1212/WNL.0000000000005180
Barros SR, Parreira SCR, Miranda AFB, Pereira AMB, Campos NMP (2018) New Insights in Vanishing White Matter Disease: Isolated Bilateral Optic Neuropathy in Adult Onset Disease. J Neuroophthalmol 38:42–46
pubmed: 28902089
doi: 10.1097/WNO.0000000000000565
Accogli A, Brais B, Tampieri D, La Piana R (2019) Long-standing psychiatric features as the only clinical presentation of vanishing white matter disease. J Neuropsychiatry Clin Neurosci 31:276–279
Trevisan L, Grazzini M, Cianflone A, Accogli A, Finocchi C, Capello E, Saitta L, Grandis M, Roccatagliata L, Mandich P (2021) An eleven-year history of Vanishing White Matter Disease in an adult patient with no cognitive decline and EIF2B5 mutations. A case report. Neurocase 27:452–456
Xu L, Zhong M, Yang Y, Wang M, An N, Xu X, Zhu Y, Li Z, Chen H, Zhao R, Zheng X (2022) Adult-onset vanishing white matter in a patient with EIF2B3 variants misdiagnosed as multiple sclerosis. Neurol Sci 43:2659–2667
Bugiani M, Boor I, Powers JM, Scheper GC, van der Knaap MS (2010) Leukoencephalopathy with vanishing white matter: a review. J Neuropathol Exp Neurol 69:987–996
pubmed: 20838246
doi: 10.1097/NEN.0b013e3181f2eafa
Spilka R, Ernst C, Bergler H, Rainer J, Flechsig S, Vogetseder A, Lederer E, Benesch M, Brunner A, Geley S, Eger A, Bachmann F, Doppler W, Obrist P, Haybaeck J (2014) eIF3a is over-expressed in urinary bladder cancer and influences its phenotype independent of translation initiation. Cell Oncol (Dordr) 37:253–267
doi: 10.1007/s13402-014-0181-9
Abbink TEM, Wisse LE, Jaku E, Thiecke MJ, Voltolini-Gonzalez D, Fritsen H, Bobeldijk S, Ter Braak TJ, Polder E, Postma NL, Bugiani M, Struijs EA, Verheijen M, Straat N, van der Sluis S, Thomas AAM, Molenaar D, van der Knaap MS (2019) Vanishing white matter: deregulated integrated stress response as therapy target. Ann Clin Transl Neurol 6:1407–1422
pubmed: 31402619
pmcid: 6689685
doi: 10.1002/acn3.50826
Leegwater PA, Vermeulen G, Konst AA, Naidu S, Mulders J, Visser A, Kersbergen P, Mobach D, Fonds D, van Berkel CG, Lemmers RJ, Frants RR, Oudejans CB, Schutgens RB, Pronk JC, van der Knaap MS (2001) Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter. Nat Genet 29:383–388
pubmed: 11704758
doi: 10.1038/ng764
van der Knaap MS, Leegwater PA, Konst AA, Visser A, Naidu S, Oudejans CB, Schutgens RB, Pronk JC (2002) Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter. Ann Neurol 51:264–270
pubmed: 11835386
doi: 10.1002/ana.10112
Huber T, Herwerth M, Alberts E, Kirschke JS, Zimmer C, Ilg R (2017) Automated segmentation reveals silent radiographic progression in adult-onset vanishing white-matter disease. Neuroradiol J 30:5–9
pubmed: 27864579
doi: 10.1177/1971400916678222
Fogli A, Boespflug-Tanguy O (2006) The large spectrum of eIF2B-related diseases. Biochem Soc Trans 34:22–29
pubmed: 16246171
doi: 10.1042/BST0340022
Mierzewska H, van der Knaap MS, Scheper GC, Jurkiewicz E, Schmidt-Sidor B, Szymanska K (2006) Leukoencephalopathy with vanishing white matter due to homozygous EIF2B2 gene mutation First Polish cases. Folia Neuropathol 44:144–148
pubmed: 16823698
Klingelhoefer L, Misbahuddin A, Jawad T, Mellers J, Jarosz J, Weeks R, Ray Chaudhuri K (2014) Vanishing white matter disease presenting as opsoclonus myoclonus syndrome in childhood–a case report and review of the literature. Pediatr Neurol 51:157–164
pubmed: 24938145
doi: 10.1016/j.pediatrneurol.2014.03.008
Van Haren K, Bonkowsky JL, Bernard G, Murphy JL, Pizzino A, Helman G, Suhr D, Waggoner J, Hobson D, Vanderver A, Patterson MC, Consortium G (2015) Consensus statement on preventive and symptomatic care of leukodystrophy patients. Mol Genet Metab 114:516–526
pubmed: 25577286
doi: 10.1016/j.ymgme.2014.12.433
Stellingwerff MD, Al-Saady ML, van de Brug T, Barkhof F, Pouwels PJW, van der Knaap MS (2021) MRI natural history of the leukodystrophy vanishing white matter. Radiology 300:671–680
pubmed: 34184934
doi: 10.1148/radiol.2021210110
Wu Y, Pan Y, Du L, Wang J, Gu Q, Gao Z, Li J, Leng X, Qin J, Wu X, Jiang Y (2009) Identification of novel EIF2B mutations in Chinese patients with vanishing white matter disease. J Hum Genet 54:74–77
pubmed: 19158808
doi: 10.1038/jhg.2008.10
Slynko I, Nguyen S, Hamilton EMC, Wisse LE, de Esch IJP, de Graaf C, Bruning JB, Proud CG, Abbink TEM, van der Knaap MS (2021) Vanishing white matter: eukaryotic initiation factor 2B model and the impact of missense mutations. Mol Genet Genomic Med 9:e1593
pubmed: 33432707
pmcid: 8104162
doi: 10.1002/mgg3.1593
Deng J, Zhou L, Zhang J, Chang X, Jiang Y, Wang J, Wu Y (2021) Correlation between genotype and age of onset in leukoencephalopathy with vanishing white matter. Front Genet 12:729777
pubmed: 34745209
pmcid: 8564072
doi: 10.3389/fgene.2021.729777
Maletkovic J, Schiffmann R, Gorospe JR, Gordon ES, Mintz M, Hoffman EP, Alper G, Lynch DR, Singhal BS, Harding C, Amartino H, Brown CM, Chan A, Renaud D, Geraghty M, Jensen L, Senbil N, Kadom N, Nazarian J, Yuanjian F, Zuyi W, Hartka T, Morizono H, Vanderver A (2008) Genetic and clinical heterogeneity in eIF2B-related disorder. J Child Neurol 23:205–215
pubmed: 18263758
doi: 10.1177/0883073807308705
Fogli A, Schiffmann R, Hugendubler L, Combes P, Bertini E, Rodriguez D, Kimball SR, Boespflug-Tanguy O (2004) Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients. Eur J Hum Genet 12:561–566
pubmed: 15054402
doi: 10.1038/sj.ejhg.5201189
Fogli A, Schiffmann R, Bertini E, Ughetto S, Combes P, Eymard-Pierre E, Kaneski CR, Pineda M, Troncoso M, Uziel G, Surtees R, Pugin D, Chaunu MP, Rodriguez D, Boespflug-Tanguy O (2004) The effect of genotype on the natural history of eIF2B-related leukodystrophies. Neurology 62:1509–1517
pubmed: 15136673
doi: 10.1212/01.WNL.0000123259.67815.DB
Singh RR, Livingston J, Lim M, Berry IR, Siddiqui A (2017) An unusual neuroimaging finding and response to immunotherapy in a child with genetically confirmed vanishing white matter disease. Eur J Paediatr Neurol 21:410–413
pubmed: 27665184
doi: 10.1016/j.ejpn.2016.08.012
Zhou L, Li P, Chen N, Dai LF, Gao K, Liu YN, Shen L, Wang JM, Jiang YW, Wu Y (2019) Modeling vanishing white matter disease with patient-derived induced pluripotent stem cells reveals astrocytic dysfunction. CNS Neurosci Ther 25:759–771
pubmed: 30720246
pmcid: 6515702
doi: 10.1111/cns.13107
Wong YL, LeBon L, Basso AM, Kohlhaas KL, Nikkel AL, Robb HM, Donnelly-Roberts DL, Prakash J, Swensen AM, Rubinstein ND, Krishnan S, McAllister FE, Haste NV, O'Brien JJ, Roy M, Ireland A, Frost JM, Shi L, Riedmaier S, Martin K, Dart MJ, Sidrauski C (2019) eIF2B activator prevents neurological defects caused by a chronic integrated stress response. Elife 9(8):e42940
Dooves S, Leferink PS, Krabbenborg S, Breeuwsma N, Bots S, Hillen AEJ, Jacobs G, van der Knaap MS, Heine VM (2019) Cell replacement therapy improves pathological hallmarks in a mouse model of leukodystrophy vanishing white matter. Stem Cell Reports 12:441–450
pubmed: 30799272
pmcid: 6411482
doi: 10.1016/j.stemcr.2019.01.018